WHAT IS THE DISEASE PREVENTION & CONTROL SUMMIT?


The Disease Prevention and Control Summit is a two day virtual event bringing together those currently working hard to ease the globe out of the COVID-19 pandemic, and to prevent it from happening again.


Sessions range from pharma focused panels discussing vaccine strategies, drug development and infection control, to sessions looking at technology, data, economics and developing countries.


Speakers include high level CEOs and scientists, from pharma and biotech, to leading regulators, government personnel, technology experts and academics.
 

Sign Up for Event Updates

By submitting, you agree to get up-to-date information, exclusive offers and the latest information via email about Disease Prevention & Control Summit America.

75+ Speakers Include

robert redfield CDC disease prevention and control

 

Robert Redfield , Director, Centers for Disease Control and Prevention

Robert was appointed as the Director of the CDC by the President of the United States in 2018, following his many years of being a public health leader actively engaged in clinical research and care of chronic human viral infections and infectious diseases. He has made several important contributions to the early scientific understanding of HIV infection, and has become a key public figure in the fight against COVID-19.

mike ryan disease prevention and control

 

Mike Ryan , Executive Director of WHO Health Emergencies Programme, World Health Organization

Mike is currently leading the WHO's emergency response efforts, and is a former surgeon and epidemiologist specialising in infectious disease and public health.

He was a Senior Advisor on the Polio eradication for the Global Polio Eradication Initiative, and was an Operational Coordinator of the WHO's response to the SARS outbreak.

Paula annunziato disease prevention and control

 

Paula Annunziato , VP and Therapeutic Area Head, Vaccines Clinical Research Merck Research Labs

During her time at Merck Research Labs, Paula has been responsible for leading the Zostavax (shingles) and Gardasil (HPV) vaccine teams, as well as the paediatric and adult vaccine sections.

She has a wealth of experience running vaccine teams and developing key vaccines, even in her prior role as Associate Professor of Clinical Paediatrics at Columbia University, where she worked on the reactivation of the varicella zoster virus.

jacob glanville disease prevention and control

 

Jacob Glanville PHD , Founding Partner, CEO and President, Distributed Bio

Jacob and his teams apply computationally-guided immunoengineering methods to enable a new generation of monoclonal antibody discovery and universal vaccine design. Jacob is also the inventor of the Centivax universal vaccine technology for influenza, HIV, and other rapidly mutating pathogens

Fun fact: Netflix covered Jacob and his team in their hit documentary ‘Pandemic’

Rino Rappouli Disease Prevention and Control

 

Rino Rappuoli , Chief Scientist & Head of External Research and Development (R&D), GlaxoSmithKline Vaccines

Rino is globally known for his extensive work in vaccines and immunology, and is actively involved in the research and development of vaccines against meningococcal disease, and avian and pandemic influenza. 

Rino led the development of the first recombinant bacterial vaccine against pertussis, the adjuvanted influenza vaccines, and the conjugate vaccine against meningococcal-C disease.

henry ji disease prevention and control

 

Henry Ji , Chairman, President and CEO, Sorrento Therapeutics

Henry co-founded Sorrento Therapeutics in 2006, with an aim to develop therapeutic approaches for cancer. More recently, Sorrento Therapeutics have been active in the COVID-19 space with an antibody cocktail called COVI-SHIELD, and the newly launched I-Cell COVID-19 Cellular Vaccine Program, which is expected to elicit both T cell and B cell immunities against SARS-CoV-2. 

neeta verma Disease Prevention and Control

 

Neeta Verma , Director General, National Informatics Center, Government of India

Neeeta has been instrumental in implementing high impact digital initiatives across India, and is involved in the launch and development of the breakthrough contact-tracing app Aarogya Setu, to track COVID-19 movements in India.

The app currently sits at over 100 million downloads, and is one of the most advanced and widely used contact tracing apps to date. 

joseph kim disease prevention and control

 

Joseph Kim , CEO, Inovio Pharmaceuticals

Joseph is an internationally recognized leader in cancer and infection diseases, in both scientific and public policy arenas, founding Inovio Pharmaceuticals in 1983.

Inovio is one of the leading biotech companies working hard to develop a vaccination for COVID-19 and currently has 115 vaccine candidates in development, and phase-1 human trials which started in June 2020.

Laura Kahn Disease Prevention and Control

 

Laura Kahn , Research Scholar, Princeton University , Co-Founder, One Health Initiative

Laura co-founded the One Health Initiative, which seeks to improve the health of all species by increasing communication and collaboration between human, animal and environmental health specialists. She is an expert advisor in the field of zoonosis and has published a number of books on topics surrounding the politics of antimicrobial resistance, one health, and trust in leadership during epidemics. 

Fun fact: The 2nd Edition of Laura’s book “Who’s in Charge?: Leadership during Epidemics, Bioterror Attacks, and Other Public Health Crises” was published earlier this year.

peter marks disease prevention and control

 

Peter Marks , Director, Center for Biologics Evaluation and Research (CBER), FDA

Peter has been with CBER since 2012, becoming Board Director in 2016, is board certified in internal medicine, hematology, medical oncology, and is a Fellow of the American College of Physicians. CBER is responsible for assuring the safety, purity, potency and effectiveness of biologics and related products, such as vaccines and cell therapies. 

lisa jarvis Disease Prevention and Control

 

Lisa Jarvis , Senior Correspondent, C&EN

Lisa tracks big pharma and biotech companies, and specialises in weaving together the business and science between developing drugs, and has reported on important issues such as Ebola, orphan drugs, gender diversity in the drug industry and more recently, COVID-19. Articles to note include “How big pharma firms are quietly collaborating on new coronavirus antivirals” and “The race to pick the best medicines to try against coronavirus”.

View All Speakers

TOPIC AREAS

 

COVID-19

Infection Control & One Health

Vaccines

Vaccine Safety

Drug Discovery, Development & Trials

Manufacturing Drugs & Vaccines

Diagnostics

Contact Tracing

Contact Mapping

Quarantine & Border Control

Developing World

Funding, Investment & Economics

 

 

WHO ATTENDS?

 

Pharma Biotech Vaccine and Drug Developers Vaccine and Drug Manufacturers Epidemiologists Infectious Disease Specialists Infection Control Hospitals and Care Facilities Health Insurance Government Public Health Homeland Security Biodefense Emergency Services Research Organizations Universities Charities Foundations NGOs Vendors 

 

WHO SPONSORS?

 

Pharma Biotech Vaccines CROs CMO Big Data Tech Mapping Contact Tracing Diagnostics Devices Protective Equipment & Clothing

 

Sponsorship Opportunities

 

The Disease Prevention & Control Summit America is an incredible marketing opportunity for world class solution providers. We’ve created some really exciting and valuable packages to enable you to keep in contact with the key players in the disease control & prevention industry whilst not being able to travel or meet face to face. Email joseph.sica@terrapinn.com to learn more.

Get Involved At Disease Prevention & Control Summit America

 

For Sponsorship Opportunities:

Joe Sica
joseph.sica@terrapinn.com
t/ +1 860 508 6307

 

 

 

For Speaking Opportunities:

Joan Shutt
joan.shutt@terrapinn.com
t/ +1 646 619 1775

 

 

 

For Marketing Opportunities:

Shannon McGorry
shannon.mcgorry@terrapinn.com
t/ +1 646 619 1840